ResearcherNorth Dakota State UniversityActive in the last 2 years

Anurag Banerjee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-9667-0898; OpenAlex author ID A5125412391. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy. Co-author DOI 10.3390/biom16020269 ↗
Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer. First author DOI 10.1016/j.ijpharm.2024.124753 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paras Mani Giri · 2 shared papers, 2024–2026 · strength 0.61
- Paper Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy. DOI 10.3390/biom16020269 ↗
- Paper Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse… DOI 10.1016/j.ijpharm.2024.124753 ↗
Buddhadev Layek · 2 shared papers, 2024–2026 · strength 0.61
- Paper Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy. DOI 10.3390/biom16020269 ↗
- Paper Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse… DOI 10.1016/j.ijpharm.2024.124753 ↗
Yongki Choi · 1 shared paper, 2026 · strength 0.36
- Paper Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy. DOI 10.3390/biom16020269 ↗
Philip Salu · 1 shared paper, 2024 · strength 0.26
- Paper Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse… DOI 10.1016/j.ijpharm.2024.124753 ↗
Katie M. Reindl · 1 shared paper, 2024 · strength 0.26
- Paper Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse… DOI 10.1016/j.ijpharm.2024.124753 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.